Skip to content

PFM Health Sciences, LP 13F Holdings · Q2 2026

PFM Health Sciences, LP reported 96 securities worth $1.17B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: ASND (5.34%), AXSM (4.61%), LLY (4.04%). Among its top 25 positions this quarter: 6 new, 8 added, 11 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1ASNDASCENDIS PHARMA A/S$62.2M5.34%233,171New
2AXSMAXSOME THERAPEUTICS INC.$53.8M4.61%219,596Trimmed
3LLYELI LILLY & CO$47.1M4.04%39,258Trimmed
4JAZZJAZZ PHARMACEUTICALS PLC$38.7M3.32%160,768Trimmed
5HUMHUMANA INC$37.5M3.22%94,375New
6UNHUNITEDHEALTH GROUP INC$36.7M3.15%88,276Added
7NBIXNEUROCRINE BIOSCIENCES INC$36.0M3.09%213,407Trimmed
8INBXINHIBRX BIOSCIENCES INC$29.2M2.51%308,385Added
9UTHRUNITED THERAPEUTICS CORP DEL$27.1M2.32%49,991Trimmed
10RVMDREVOLUTION MEDICINES INC$26.8M2.30%143,222Added
11ICLRICON PUB LTD CO$23.7M2.03%136,482Added
12THCTENET HEALTHCARE CORP$23.7M2.03%126,572Trimmed
13EWEDWARDS LIFESCIENCES CORP$22.7M1.94%250,453Trimmed
14WATWATERS CORP$22.4M1.93%59,825Added
15CNCCENTENE CORP DEL$21.6M1.86%337,067Added
16PENPENUMBRA INC$19.0M1.63%60,221Trimmed
17BBIOBRIDGEBIO PHARMA INC$18.9M1.62%253,358Trimmed
18SYKSTRYKER CORPORATION$17.8M1.53%56,637Added
19MTDMETTLER TOLEDO INTERNATIONAL$17.0M1.46%13,344New
20INDVINDIVIOR PHARMACEUTICALS INC$16.5M1.41%401,208Trimmed
21CYTKCYTOKINETICS INC$16.3M1.40%191,686New
22MRKMERCK & CO INC$16.3M1.40%127,118New
23LNTHLANTHEUS HLDGS INC$16.2M1.39%146,403New
24COOCOOPER COS INC$15.8M1.36%220,890Added
25MDGLMADRIGAL PHARMACEUTICALS INC$15.7M1.35%29,313Trimmed

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR